James Seddon
@jaseddon.bsky.social
450 followers 75 following 7 posts
Paediatric Infectious Diseases doctor and TBologist
Posts Media Videos Starter Packs
Reposted by James Seddon
jay-achar.bsky.social
Great to see this published after the hard work in Stockholm and Cape Town! How should we think about aerosol detection of #tuberculosis? Is it a diagnostic test? Could it help us prioritize prevention activities? Much more work to do, but exciting nonetheless @climeresearchgroup.bsky.social @ki.se
ofidjournal.bsky.social
Detection of aerosolized Mycobacterium tuberculosis DNA from adults being investigated for pulmonary tuberculosis using an electrostatic sampler in a South African primary care setting

✅ Just Accepted
#IDSky
🔗 https://bit.ly/474fRq0
Reposted by James Seddon
Reposted by James Seddon
nejm.org
NEJM.org @nejm.org · Feb 5
In the endTB trial, researchers assessed the efficacy and safety of five 9-month, all-oral treatment regimens, as compared with the evolving standard of care, in participants with rifampin-resistant, fluoroquinolone-susceptible tuberculosis. nej.md/3WFFJTv

#MedSky #IDSky
The New England Journal of Medicine    
Oral Regimens for Rifampin-Resistant Tuberculosis 
A PLAIN LANGUAGE SUMMARY    

Visual representation of a patient with rifampin-resistant tuberculosis. 

Read the full Plain Language Summary at NEJM.org.
Reposted by James Seddon
agbasteiro.bsky.social
Interesting paper published today in Chest, led by Cheng Chen and Leo Martinez. High frequency of reversions observed when serial QTF is performed. Reversion rates decreased with time from exposure and at older ages. Data from 4 different countries

@chest

linkinghub.elsevier.com/retrieve/pii...
Redirecting
linkinghub.elsevier.com
jaseddon.bsky.social
Thanks Patrick. All a bit unclear. Probably a combination of better diagnostics in adults meaning that children less exposed, and really thorough screening at baseline to exclude any hint of early disease. I think that some of the efficacy seen in most TPT trials is in treating early disease.
jaseddon.bsky.social
Thanks Tom. I suspect that the better you make the baseline screening, the less effective the TPT becomes as you identify and exclude very early disease which is probably what most TPT is treating. But yes, for me, I will give levofloxacin to children <5 years exposed to MDR-TB. Adults, hmmm.
jaseddon.bsky.social
And finally the meta-analysis of the two trials in NEJM Evidence with a nice article on the world's weird obsession with P values.

evidence.nejm.org/doi/full/10....
evidence.nejm.org/doi/full/10....
jaseddon.bsky.social
Also out in this issue of NEJM. Results from the VQUIN trial. www.nejm.org/doi/full/10....
jaseddon.bsky.social
This journey began for me in 2009. Beyond excited to see this now out in print. Thank you to everyone (a very large cast) who made this happen. www.nejm.org/doi/full/10....
Reposted by James Seddon
salonifruehauf.bsky.social
A reminder on #WorldChildrensDay that 1.3million children fell ill with #tuberculosis in 2023, causing 200,000 paediatric deaths from a disease that's curable & preventable.

Govts & funders must urgently prioritise children in research funding & program implementation. msfaccess.org/tactic-test-...
TACTIC: Test, Avoid, Cure TB in Children
Survey of adoption of WHO paediatric TB guidelines into national policy frameworks in 14 countries
msfaccess.org